Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage
- PMID: 9221801
- DOI: 10.1002/(sici)1097-0215(19970620)74:3<255::aid-ijc4>3.0.co;2-y
Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage
Abstract
The G1/S checkpoint of the cell cycle is regulated by p16, p53 and RB tumor suppressor genes. Loss of expression of the p16INK4 tumor suppressor protein, the product of the CDKN2 gene, has been associated with a wide variety of human malignancies. Mutations, loss of heterozygosity and deletions of the CDKN2 locus have been reported in sporadic and familial cutaneous malignant melanomas (CMM). To investigate the role of the alterations of p16 expression in melanoma, we evaluated by immunohistochemistry the p16 expression and cell proliferation in 79 primary CMM and 10 benign melanocytic nevi (BMN). Forty-six melanomas (58%) and all BMN were found to be p16 positive; 33 melanomas (42%) were considered p16 negative. The extent of invasion according to Clark was significantly higher in p16-negative tumors than in p16-positive tumors. Cell proliferation as expressed by the proportion of positive cells in Ki-67 immunostaining was found to be significantly higher in p16-negative tumors than in p16-positive tumors, although there was no significant difference in the mitotic index between p16-positive and p16-negative tumors. In p16-positive tumors, the number of Ki-67-positive cells correlated with the mitotic index; in p16-negative tumors, there was no correlation between these parameters. Our data suggest that loss of p16 expression is more common in advanced melanomas, and that G1/S checkpoint regulation is disrupted in p16-negative melanomas. Our results show that loss of p16 expression is a common event in primary melanomas, which further substantiates the role of p16 as a major tumor suppressor.
Similar articles
-
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.Cancer Res. 1995 Jul 1;55(13):2713-8. Cancer Res. 1995. PMID: 7796391
-
p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma.J Cutan Pathol. 1998 Jul;25(6):291-6. doi: 10.1111/j.1600-0560.1998.tb01748.x. J Cutan Pathol. 1998. PMID: 9694617
-
p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.Int J Cancer. 1997 Feb 20;74(1):26-30. doi: 10.1002/(sici)1097-0215(19970220)74:1<26::aid-ijc5>3.0.co;2-2. Int J Cancer. 1997. PMID: 9036865
-
Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.
-
Involvement of the p16INK4 (CDKN2) gene in familial melanoma.Melanoma Res. 1996 Apr;6(2):139-45. doi: 10.1097/00008390-199604000-00009. Melanoma Res. 1996. PMID: 8791272 Review.
Cited by
-
Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.Int J Clin Exp Pathol. 2015 Sep 1;8(9):9742-51. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26617684 Free PMC article. Review.
-
Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.J Cutan Pathol. 2023 Feb;50(2):155-168. doi: 10.1111/cup.14342. Epub 2022 Nov 4. J Cutan Pathol. 2023. PMID: 36261329 Free PMC article.
-
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?Br J Cancer. 2006 Aug 21;95(4):496-505. doi: 10.1038/sj.bjc.6603283. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880792 Free PMC article.
-
Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.Genes Chromosomes Cancer. 2010 May;49(5):425-38. doi: 10.1002/gcc.20753. Genes Chromosomes Cancer. 2010. PMID: 20140953 Free PMC article.
-
p16 Expression Is Lost in Severely Atypical Cellular Blue Nevi and Melanoma Compared to Conventional, Mildly, and Moderately Atypical Cellular Blue Nevi.ISRN Dermatol. 2014 Jan 22;2014:348417. doi: 10.1155/2014/348417. eCollection 2014. ISRN Dermatol. 2014. PMID: 24587914 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous